Zhengye Biotechnology Holding LtdZYBT
Price$1.20

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Dec 2025
Market Price $1.20Price as of 30 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 7.8%
Volatility vs market (adjusted beta)0.63

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetZhengye Biotechnology Holding LtdZYBTHealth Care
Valuation
P/E—
P/S0.6×
P/B0.2×
EV / Revenue0.8×
EV / EBITDA-6.6×
Profitability
Gross margin20.5%
Operating margin-60.6%
Net margin-60.0%
FCF margin70.9%
Returns
ROE-3.3%
ROA-2.3%
ROIC—
Growth
Revenue growth (YoY)-34.8%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.24×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.